Díaz JV

Language: Spanish
References: 13
Page: 37-39
PDF size: 120.67 Kb.

Text Extraction

No abstract

REFERENCES

1. Poole K. Efflux-mediated multiresistance in Gram–negative bacteria. Clin Microbiol Infect 2004;10:12-26.

2. Poole K. Pseudomonas aeruginosa. Capítulo 26 en: Frontiers in antimicrobial resistance. ASM Press, 2005. p. 355-66.

3. Richards MJ, Edwards J, et al. Nosocomial infections in medical intensive care units in the United States. Critical Care Medicine 1999;27:887-92.

4. Jones RN, Kirby JT, Rhomberg PR. Comparative activity of meropenem in US medical centers (2007): initiating the 2nd decade of MYSTIC program surveillance. Diagnos Microbiol and Infect Dis 2008;61:203-13.

5. Hocquet D, Bertrand X, et al. Genetic and phenotypic variations of a resistant Pseudomonas aeruginosa epidemic clone. Antimicrob Agents Chem 2003;47(6):1887-94.

6. Fluit A, Schmitz F. Resistance integrons and super-integrons. Clin Microb Infect 2004;10:272-88.

7. Walsh T. Clinically significant carbapenemases: an update. Curr Opin Infect Dis 2008;21:367-71.

8. Walsh T, Toleman M. Metallo-β-lactamases: quiet before the storm. Clin Microbiol Rev 2005;18(2):306-25.

9. Lahey Clinic. Amino Acid Sequences for TEM, SHV and OXA Extended-Spectrum and Inhibitor Resistant ß-Lactamases. Citado: el 30 de septiembre de 2008. Disponible en: http://lahey.org/studies/.

10. Garza U, Tinoco P, Silva J, Morfin R, Rodríguez E, León G. Metallo-β-lactamase IMP-18 is located in class I integron (In 96) in a clinical isolate of Pseudomonas aeruginosa from Mexico. International Journal of Antimicrobial Agents 2008;31:76-90.

11. Juretschko S, La Bomardi V. Acccuracies of β-lactam susceptibility test results for Pseudomonas aeruginosa with four automated systems (BD Phoenix, Microscan Walk Away, Vitek and Vitek 2). J Clinical Microbiol 2007;45(4):1339-42.

12. Giamarellou H, Kanellakoulou K, et al. Current therapies for Pseudomonas aeruginosa. Crit Care Clin 2008;24:261-78.

13. Micek S, Lloyd A, et al. Pseudomonas aeruginosa bloodstream infection: importance of appropriate initial antimicrobial treatment. Antomicrob Agents Chemother 2005;49(4):1306-11.